Tod Bedilion

Tod Bedilion is a strategically oriented business development professional with over 20 years of experience in Translational Medicine and IVD technologies. They began their career as the Research Director at Synteni, where they were the first employee and played a key role in commercializing Stanford's original microarray technology. Tod then held positions at Roche, serving as the Director of Technology Management and later as the Senior Director of Diagnostic Biomarkers, contributing to the strategy and sourcing of novel biomarker content. Currently, Tod is the Senior Director of Business Development for Roche Molecular Solutions and is pursuing a Ph.D. in Cell, Molecular, and Developmental Biology at UCLA.